This topic contains a solution. Click here to go to the answer

Author Question: The following intervention is appropriate related to insulin therapy: a. short-acting insulin ... (Read 89 times)

joesmith1212

  • Hero Member
  • *****
  • Posts: 549
The following intervention is appropriate related to insulin therapy:
 a. short-acting insulin should be given one hour before meals.
  b. client needs to eat within 30 minutes after rapid-acting insulin injection.
  c. after initiation of insulin therapy, a honeymoon phase occurs that then allows a reduced amount of insulin on a permanent basis.
  d. insulin sensitivity can be determined by analyzing pre-meal blood glucose, insulin dose administered, and food eaten.

Question 2

Intensive insulin therapy includes the following:
 a. emphasis on control of carbohydrates and portion sizes.
  b. standard insulin dosages based on total kcalories per meal.
  c. insulin injection is usually limited to one evening dose.
  d. a flexible eating pattern.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jesse.fleming

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

d

Answer to Question 2

a





 

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library